Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Editor's Note

Editor's Note EDITORIAL Editor’s Note: Almost no one in otolaryngology–head and neck surgery (OHNS) is exempt from some kind of conflict of interest in reporting or interpreting research information. The problem of influence is often internal and potentially high when we, as surgeons, describe new procedures that advance our individual technical value. External influence can be enor- mous when it is pushed by instrument or drug company venture. What we study, interpret, and write for head and neck medicine is passed on to the rest of medicine because of the high incidence and prevalence of OHNS patient complaints. Although we are a small number of specialists, our writings influence many. Previous editorial policy, stated by Catherine DeAngelis et al ( JAMA. 2001;286:89-91), reflects a need to acknowledge the influence that drug companies have exerted on medical research reporting. The JAMA September 12, 2001, editorial reprinted below ( JAMA. 2001;286:1232-1234) states how the American Medical Association’s journals intend to minimize such effects. The drug company’s influential tint is darkest when the prize is recognition as the drug of choice for treatment of chronic disease in large populations, yet we in OHNS are not exempt from the same potential stain. It is important http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Otolaryngology - Head & Neck Surgery American Medical Association

Editor's Note

Abstract

EDITORIAL Editor’s Note: Almost no one in otolaryngology–head and neck surgery (OHNS) is exempt from some kind of conflict of interest in reporting or interpreting research information. The problem of influence is often internal and potentially high when we, as surgeons, describe new procedures that advance our individual technical value. External influence can be enor- mous when it is pushed by instrument or drug company venture. What we study, interpret, and write for head and...
Loading next page...
 
/lp/american-medical-association/editor-s-note-GG40ZmQLLV
Publisher
American Medical Association
Copyright
Copyright 2001 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6181
eISSN
2168-619X
DOI
10.1001/archotol.127.10.1178
Publisher site
See Article on Publisher Site

Abstract

EDITORIAL Editor’s Note: Almost no one in otolaryngology–head and neck surgery (OHNS) is exempt from some kind of conflict of interest in reporting or interpreting research information. The problem of influence is often internal and potentially high when we, as surgeons, describe new procedures that advance our individual technical value. External influence can be enor- mous when it is pushed by instrument or drug company venture. What we study, interpret, and write for head and neck medicine is passed on to the rest of medicine because of the high incidence and prevalence of OHNS patient complaints. Although we are a small number of specialists, our writings influence many. Previous editorial policy, stated by Catherine DeAngelis et al ( JAMA. 2001;286:89-91), reflects a need to acknowledge the influence that drug companies have exerted on medical research reporting. The JAMA September 12, 2001, editorial reprinted below ( JAMA. 2001;286:1232-1234) states how the American Medical Association’s journals intend to minimize such effects. The drug company’s influential tint is darkest when the prize is recognition as the drug of choice for treatment of chronic disease in large populations, yet we in OHNS are not exempt from the same potential stain. It is important

Journal

JAMA Otolaryngology - Head & Neck SurgeryAmerican Medical Association

Published: Oct 1, 2001

References